Clinical trial
Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular Carcinoma
NCT03338166 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular Carcinoma
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 2, 2018
- Completion date
- December 31, 2018
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma